[Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
To evaluate long-term efficacy of hepatitis B vaccination in newborns. In the past 13 years we followed up the children who had been immunized with hepatitis B vaccine at birth in 1986 every other year. At each follow-up visit, every child was tested for HBsAg, anti-HBs and anti-HBc. HBsAg positive rate of these birth cohort was low (range between 0.46% and 0.98%) during 13 years' follow-up. Long-term efficacy of the vaccination in preventing HBsAg carriage was confirmed. Thirteen years later no booster was after needed.